Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -37.50 -1.95% 1,890.50 1,887.00 1,889.00 1,911.00 1,862.00 1,889.50 534,584 16:35:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1,623.2 229.8 91.7 21.5 4,574

Hikma Pharmaceuticals Plc Director/PDMR Shareholding

13/03/2019 1:50pm

UK Regulatory (RNS & others)


RNS Number : 7823S

Hikma Pharmaceuticals Plc

13 March 2019

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
 b)   Nature of the             Market purchase of 20,000 Ordinary Shares by 
       transaction               Capital Investment & Brokerage / Jordan Ltd. 
                                 Co for and on behalf of Mazen Darwazah. 
 c)   Price(s) and              Price(s): GBP15.8198 
       volume(s)                 Volume(s): 20,000 
 d)   Aggregated information 
        *    Volume               20,000 
        *    Price 
 e)   Date of the transaction   13 March 2019 
 f)   Place of the              London Stock Exchange (XLON) 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

13 March 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

March 13, 2019 09:50 ET (13:50 GMT)

1 Year Hikma Pharmaceuticals Chart

1 Year Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart

1 Month Hikma Pharmaceuticals Chart
Your Recent History
Hikma Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191215 21:22:36